Adrian Enriquez

La Jolla Institute for Immunology

0000-0002-8225-6688

Projects

COVID-19: Structural analysis of SARS-CoV-2 proteins to understand virus immunogenicity and develop therapeutic interventions for COVID19

Lead Institution

La Jolla Institute for Immunology

Principal Investigator

Erica Saphire

Effective and rapid responses to the ongoing COVID-19 pandemic must involve vaccination, therapies and serology. Our laboratory has the required expertise to produce and manage significant volumes of…

Structural Analysis of Lineage I Lassa Virus Glycoprotein

Lead Institution

La Jolla Institute for Immunology

Principal Investigator

Erica Saphire

Lassa virus (LASV), the causative agent of Lassa hemorrhagic fever, is endemic in Western Africa, infecting over 100,000 people every year, resulting in roughly 5,000 deaths—yet no vaccines are…

Medical Defenses Against Emerging Infectious Disease

Lead Institution

La Jolla Institute for Immunology

Principal Investigator

Erica Saphire

Hemorrhagic fever viruses like Ebola, Marburg, and Lassa cause up to 90% lethality. To study these re-emerging threats to human health and develop the needed vaccines and antivirals, our laboratory…